Trial Profile

A Phase 2a Proof of Concept Study of LSD in a Severe Pain

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 03 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lysergide (Primary)
Indications Pain
Focus Proof of concept; Therapeutic Use
Sponsors Definium Therapeutics

Most Recent Events

12 Jan 2026 According to Definium Therapeutics media release, MindMed is now called as Definium Therapeutics.
12 May 2021 New trial record
05 May 2021 According to a Mindmed media release, for the commencement of Project Angie, the company will initiate this study. The company is currently preparing a pre-IND briefing package for this Phase 2a Proof of Concept study which it plans to submit to the FDA in the second half of 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com